Nashville antithymocyte serum: a safe and efficacious agent for prophylaxis after heart transplantation.
Frist
W H
WH
Vanderbilt Transplant Center, Nashville, Tennessee.
Merrill
W H
WH
Eastburn
T E
TE
Stewart
J R
JR
Hammon
J W
JW
Fortune
D S
DS
Guy
T S
TS
Bender
H W
HW
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000945:Antigens, Differentiation, T-Lymphocyte / Q000032:analysis; D000961:Antilymphocyte Serum / Q000276:immunology*; D017252:CD3 Complex; D003586:Cytomegalovirus Infections / Q000150:complications; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology / Q000379:methods*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007958:Leukocyte Count; D008297:Male; D016853:Muromonab-CD3; D009894:Opportunistic Infections / Q000150:complications; D011948:Receptors, Antigen, T-Cell / Q000032:analysis; D016176:T-Lymphocyte Subsets / Q000276:immunology
D000911:Antibodies, Monoclonal; D000945:Antigens, Differentiation, T-Lymphocyte; D000961:Antilymphocyte Serum; D017252:CD3 Complex; D016853:Muromonab-CD3; D011948:Receptors, Antigen, T-Cell